These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6240548)

  • 1. [HBV-related antigens and genetic engineering].
    Hamada F; Mizuno K
    Rinsho Byori; 1984 Nov; 32(11):1177-83. PubMed ID: 6240548
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of genetic technics for the diagnosis and prevention of hepatitis B virus infections].
    Gerlich WH
    Internist (Berl); 1985 Feb; 26(2):63-7. PubMed ID: 2984133
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of genetic engineering on hepatitis B virus.
    Highfield PE
    Dev Biol Stand; 1985; 59():121-4. PubMed ID: 3859431
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
    Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
    J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the hepatitis B virus surface, core and E antigen genes by stable rat and mouse cell lines.
    Gough NM; Murray K
    J Mol Biol; 1982 Nov; 162(1):43-67. PubMed ID: 6296407
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between hepatitis B virus markers and quantitative HBV DNA in serum].
    Huang ZX; Chen DY; Zhang QB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):43. PubMed ID: 14761284
    [No Abstract]   [Full Text] [Related]  

  • 12. [Variations of HBV can affect the reaction of specific CTL].
    Zhou Z; Guo Y; Luo K
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):74. PubMed ID: 11856517
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

  • 15. [Structure and function of hepatitis B virus proteins].
    Loch T; Slusarczyk J
    Pol Arch Med Wewn; 1987 Dec; 78(6):341-6. PubMed ID: 3078036
    [No Abstract]   [Full Text] [Related]  

  • 16. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
    Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
    J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics.
    Misawa N; Matsumoto A; Tanaka E; Rokuhara A; Yoshizawa K; Umemura T; Maki N; Kimura T; Kiyosawa K
    J Med Virol; 2006 Jan; 78(1):68-73. PubMed ID: 16299733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection.
    Takayanagi M; Kakumu S; Ishikawa T; Higashi Y; Yoshioka K; Wakita T
    Virology; 1993 Sep; 196(1):138-45. PubMed ID: 8356791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.